DAPHNE WEEKS: Open Payments
NPI 1750981890 · GIBSONTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,617 in 55 payments from 8 companies in 2025. Trend: 2023 $1,236 · 2024 $2,085 · 2025 $15,617
Speaker / faculty: $11,220Travel & lodging: $2,581Food & beverage: $1,740Education: $76
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 20 | $14,256 |
| Alkermes, Inc. | 10 | $473 |
| Otsuka America Pharmaceutical, Inc. | 7 | $347 |
| Teva Pharmaceuticals USA, Inc. | 9 | $192 |
| Janssen Scientific Affairs, LLC | 3 | $156 |
| E.R. Squibb & Sons, L.L.C. | 4 | $137 |
| ABBVIE INC. | 1 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: INVEGA SUSTENNA, ARISTADA, COBENFY, ABILIFY MAINTENA, LYBALVI, ABILIFY ASIMTUFII, AUSTEDO XR, UZEDY.
Industry payments across FL — which companies pay providers there.
